arrow
D

Domenico Mangiameli

university of verona
H指数:6
被引数:199

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages

作者更正:CCL3 预测在产生 LIF 的巨噬细胞富集的基底样胰腺癌中,TGFβ 抑制可产生卓越反应

2026-05-220
OA
EGFR ligand Angiogenin predicts response to ALK5 inhibition in pancreatic cancer via a TNF-α paracrine axis in tumor-associated macrophages

EGFR配体血管生成素通过肿瘤相关巨噬细胞中的tnf-α 旁分泌轴预测胰腺癌对ALK5抑制的反应

2026-04-140
OAAI
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab

靶向FGFR通路不是曲妥珠单抗耐药的非选择性转移性食管胃癌患者的有效治疗策略

2023-03-111
OAAI
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer

血浆IL8是TAK1激活的生物标志物,可预测吉西他滨难治性胰腺癌患者对纳米脂质体伊立替康的耐药性

2020-09-0122
OAAI